Topal, A., & Başak, M. (2025). Evaluating the role of HER2-low versus HER2-0 status in predicting response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer. The European Research Journal, 11(5), 858-867. https://doi.org/10.18621/eurj.1704067